Peng Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peng Zhang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Handong Yang
Cardiovascular Research Center, Hubei University of Medicine, Hubei, China
3 shared publicationsYinfang Wang
Cardiovascular Research Center, Hubei University of Medicine, Hubei, China
3 shared publications- Hang Qian
Department of Cardiology, Dongfeng General Hospital, Hubei University of Medicine, Shiyan, China
2 shared publications - Xinwen Min
Sinopharm Dongfeng General Hospital (Hubei Clinical Research Center of Hypertension), Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine, Shiyan, Hubei, China
2 shared publications - Congxin Huang
Department of Cardiovascular Diseases, Renmin Hospital of Wuhan University, Wuhan City, China
1 shared publication - Dongfeng Li
Dongfeng Central Hospital, Dongfeng Motor Corporation and Hubei University of Medicine, Shiyan, China
1 shared publication
Latest Publications
- Open Access
- 12 August 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e72315
The G0/G1 Switch Gene 2 Is an Important Regulator of Hepatic Triglyceride Metabolism
Nonalcoholic fatty liver disease is associated with obesity and insulin resistance. Factors that regulate the disposal of hepatic triglycerides contribute to the development of hepatic steatosis. G0/G1 switch gene 2 (G0S2) is a target of peroxisome proliferator-activated receptors and plays an important role in regulating lipolysis in adipocytes. Therefore, we investigated whether G0S2 plays a role in hepatic lipid metabolism. Adenovirus-mediated expression of G0S2 (Ad-G0S2) potently induced fatty liver in mice. The liver mass of Ad-G0S2-infected mice was markedly increased with excess triglyceride content compared to the control mice. G0S2 did not change cellular cholesterol levels in hepatocytes. G0S2 was found to be co-localized with adipose triglyceride lipase at the surface of lipid droplets. Hepatic G0S2 overexpression resulted in an increase in plasma Low-density lipoprotein (LDL)/Very-Low-density (VLDL) lipoprotein cholesterol level. Plasma High-density lipoprotein (HDL) cholesterol and ketone body levels were slightly decreased in Ad-G0S2 injected mice. G0S2 also increased the accumulation of neutral lipids in cultured HepG2 and L02 cells. However, G0S2 overexpression in the liver significantly improved glucose tolerance in mice. Livers expressing G0S2 exhibited increased 6-(N-(7-nitrobenz-2-oxa-1-3-diazol-4-yl) amino)-6-deoxyglucose uptake compared with livers transfected with control adenovirus. Taken together, our results provide evidence supporting an important role for G0S2 as a regulator of triglyceride content in the liver and suggest that G0S2 may be a molecular target for the treatment of insulin resistance and other obesity-related metabolic disorders.
- 12 August 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (8) , e72315
Open AccessThe G0/G1 Switch Gene 2 Is an Important Regulator of Hepatic Triglyceride Metabolism
Nonalcoholic fatty liver disease is associated with obesity and insulin resistance. Factors that regulate the disposal of hepatic triglycerides contribute to the development of hepatic steatosis. G0/G1 switch gene 2 (G0S2) is a target of peroxisome proliferator-activated receptors and plays an important role in regulating lipolysis in adipocytes. Therefore, we investigated whether G0S2 plays a role in hepatic lipid metabolism. Adenovirus-mediated expression of G0S2 (Ad-G0S2) potently induced fatty liver in mice. The liver mass of Ad-G0S2-infected mice was markedly increased with excess triglyceride content compared to the control mice. G0S2 did not change cellular cholesterol levels in hepatocytes. G0S2 was found to be co-localized with adipose triglyceride lipase at the surface of lipid droplets. Hepatic G0S2 overexpression resulted in an increase in plasma Low-density lipoprotein (LDL)/Very-Low-density (VLDL) lipoprotein cholesterol level. Plasma High-density lipoprotein (HDL) cholesterol and ketone body levels were slightly decreased in Ad-G0S2 injected mice. G0S2 also increased the accumulation of neutral lipids in cultured HepG2 and L02 cells. However, G0S2 overexpression in the liver significantly improved glucose tolerance in mice. Livers expressing G0S2 exhibited increased 6-(N-(7-nitrobenz-2-oxa-1-3-diazol-4-yl) amino)-6-deoxyglucose uptake compared with livers transfected with control adenovirus. Taken together, our results provide evidence supporting an important role for G0S2 as a regulator of triglyceride content in the liver and suggest that G0S2 may be a molecular target for the treatment of insulin resistance and other obesity-related metabolic disorders.
- Open Access
- 1 September 2011
- Published by Elsevier in Molecules and Cells
- Vol. 32 (3) , 235-242
Pim Protein Kinase-3 Is Regulated by TNF-α and Promotes Endothelial Cell Sprouting
- 1 September 2011
- Published by Elsevier in Molecules and Cells
- Vol. 32 (3) , 235-242
Open AccessPim Protein Kinase-3 Is Regulated by TNF-α and Promotes Endothelial Cell Sprouting
- 19 February 2009
- Published by Wiley in Journal of Cellular Physiology
- Vol. 220 (1) , 82-90
Pim‐3 is expressed in endothelial cells and promotes vascular tube formation
Pim‐3 is a member of proto‐oncogene Pim family that encodes serine/threonine kinases. Pim proteins regulate both apoptosis and cellular metabolism by phosphorylating their substrates. Here, we report for the first time that Pim‐3 is highly expressed at mRNA and protein levels in endothelial cells (ECs). We found that Pim‐3 is concentrated at the cellular lamellipodia and co‐localized with focal adhesion kinase (FAK). Pim‐3 was dispersed from lamellipodia when ECs were treated with cytochalasin D, an inhibitor of actin polymerization. In addition, small‐interfering RNA (siRNA)‐mediated gene knockdown of Pim‐3 significantly impaired EC spreading, migration, and proliferation, leading to a reduction in tube‐like structure formation in a Matrigel assay. These results provide the novel evidence that Pim‐3 plays an essential role in EC spreading and migration, suggesting that Pim‐3 may be an important molecular target for the development of small‐molecule inhibitors of angiogenesis. J. Cell. Physiol. 220: 82–90, 2009.
- 19 February 2009
- Published by Wiley in Journal of Cellular Physiology
- Vol. 220 (1) , 82-90
Pim‐3 is expressed in endothelial cells and promotes vascular tube formation
Pim‐3 is a member of proto‐oncogene Pim family that encodes serine/threonine kinases. Pim proteins regulate both apoptosis and cellular metabolism by phosphorylating their substrates. Here, we report for the first time that Pim‐3 is highly expressed at mRNA and protein levels in endothelial cells (ECs). We found that Pim‐3 is concentrated at the cellular lamellipodia and co‐localized with focal adhesion kinase (FAK). Pim‐3 was dispersed from lamellipodia when ECs were treated with cytochalasin D, an inhibitor of actin polymerization. In addition, small‐interfering RNA (siRNA)‐mediated gene knockdown of Pim‐3 significantly impaired EC spreading, migration, and proliferation, leading to a reduction in tube‐like structure formation in a Matrigel assay. These results provide the novel evidence that Pim‐3 plays an essential role in EC spreading and migration, suggesting that Pim‐3 may be an important molecular target for the development of small‐molecule inhibitors of angiogenesis. J. Cell. Physiol. 220: 82–90, 2009.